Orchestra BioMed Holdings, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Orchestra BioMed Holdings, Inc. (OBIO) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $2.46 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-08-10
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.46M.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.78M.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.75M.
- 2022-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $2.09M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $2.46M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $2.78M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $2.75M 10-Q · filed 2026-08-10 |
| 2022-12-31 | $2.09M 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |